100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Previously searched by you
Previously searched by you
logo
ACRP-CP Exam QUESTIONS & SOLUTIONS(RATED A) $10.99
Add to cart
Quickly navigate to
Preview
  2.  
  3. ACRP-CP
  4.  
  5. ACRP-CP

Exam (elaborations)

ACRP-CP Exam QUESTIONS & SOLUTIONS(RATED A)
 0 purchase
  • Course
  • ACRP-CP
  • Institution
  • ACRP-CP

What is an ADR? - ANSWER Adverse drug reaction (ADR) 1.Pre-approval clinical experience with a new medicinal product or its new usages: all noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions. The phrase responses to a medicinal...

[Show more]

Preview 2 out of 9  pages

Document information

  • September 15, 2024
  • 9
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers

Subjects

  • acrp cp
  • acrp cp exam questions solutionsrated a
  • what is an adr answer adverse drug reaction ad
  • pre approval clinical experience with a new medic

Written for

  • ACRP-CP
  • ACRP-CP

Seller

avatar-seller
shantelleG

Reviews received

Content preview

ACRP-CP Exam QUESTIONS &
SOLUTIONS(RATED A)
What is an ADR? - ANSWER Adverse drug reaction (ADR)



1.Pre-approval clinical experience with a new medicinal product or its new usages: all noxious and
unintended responses to a medicinal product related to any dose should be considered adverse drug
reactions. The phrase responses to a medicinal product means that a causal relationship between a
medicinal product and an adverse event is at least a reasonable possibility, i.e., the relationship cannot
be ruled out.



2. Regarding marketed medicinal products: a response to a drug which is noxious and unintended and
which occurs at doses normally used in man for prophylaxis, diagnosis, or therapy of diseases or for
modification of physiological function.



What is an AE? - ANSWER Adverse event (AE)



1. Any untoward medical occurrence in a patient or clinical investigation subject administered a
pharmaceutical product and which does not necessarily have a causal relationship with this treatment.
An adverse event (AE) can therefore be any unfavourable and unintended sign (including an abnormal
laboratory finding), symptom, or disease temporally associated with the use of a medicinal
(investigational) product, whether or not related to the medicinal (investigational) product.



What is an SAE? - ANSWER Serious adverse event (SAE)



1. Results in death

2. Is life-threatening

3. Requires inpatient hospitalization or prolongation of existing hospitalization

4. Results in persistent or significant disability/incapacity

5. Is a congenital anomaly/birth defect

, What is an UADR? - ANSWER Unexpected adverse drug reaction (UADR)



1. An adverse reaction, the nature or severity of which is not consistent with the applicable product
information (e.g., IB for an unapproved IP or package insert/summary of product characteristics for an
approved product)



How frequently should the IRB/IEC conduct a CR of each ongoing trial? - ANSWER The IRB/IEC should
conduct continuing review of each ongoing trial at intervals appropriate to the degree of risk to human
subjects, but at least once per year.



What is the minimum number of members for an IRB/IEC? And what specific people need to be
involved? - ANSWER (a) At least five members.



(b) At least one member whose primary area of interest is in a nonscientific area.



(c) At least one member who is independent of the institution/trial site.



What four things should the investigator promptly report to the IRB/IEC? - ANSWER (a) Deviations from,
or changes of, the protocol to eliminate immediate hazards to the trial subjects.



(b) Changes increasing the risk to subjects and/or affecting significantly the conduct of the trial.



(c) All adverse drug reactions (ADRs) that are both serious and unexpected.



(d) New information that may affect adversely the safety of the subjects or the conduct of the trial.



For how long should the IRB/IEC retain all relevant records? - ANSWER The IRB/IEC should retain all
relevant records for a period of at least 3-years after completion of the trial and make them available
upon request from the regulatory authority(ies).

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller shantelleG. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $10.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

69052 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 15 years now

Start selling
$10.99
  • (0)
Add to cart
Added